Literature DB >> 24757366

Carlos Fernández-del Castillo Confronts The Challenge of Pancreatic Cancer: Although Progress Has Been Slow, a Renowned Expert On the Disease Sees Reasons for Hope.

Jack McCain.   

Abstract

The prognosis for patients with pancreatic cancer remains poor, but a widely recognized expert on pancreatic and biliary surgery at Massachusetts General Hospital and Harvard Medical School expresses optimism about improvements in the next decade.

Entities:  

Year:  2014        PMID： 24757366      PMCID： PMC3989085     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  14 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

Review 2.  Intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Carlos Fernández-del Castillo; N Volkan Adsay
Journal:  Gastroenterology       Date:  2010-07-19       Impact factor: 22.682

Review 3.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

4.  Pancreatic resection for pancreatic cancer.

Authors:  Jeannine Bachmann; Christoph W Michalski; Marc E Martignoni; Markus W Büchler; Helmut Friess
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

5.  FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience.

Authors:  Jason E Faris; Lawrence S Blaszkowsky; Shaunagh McDermott; Alexander R Guimaraes; Jackie Szymonifka; Mai Anh Huynh; Cristina R Ferrone; Jennifer A Wargo; Jill N Allen; Lauren E Dias; Eunice L Kwak; Keith D Lillemoe; Sarah P Thayer; Janet E Murphy; Andrew X Zhu; Dushyant V Sahani; Jennifer Y Wo; Jeffrey W Clark; Carlos Fernandez-del Castillo; David P Ryan; Theodore S Hong
Journal:  Oncologist       Date:  2013-05-08

6.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

7.  Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4).

Authors:  C Bosetti; E Lucenteforte; D T Silverman; G Petersen; P M Bracci; B T Ji; E Negri; D Li; H A Risch; S H Olson; S Gallinger; A B Miller; H B Bueno-de-Mesquita; R Talamini; J Polesel; P Ghadirian; P A Baghurst; W Zatonski; E Fontham; W R Bamlet; E A Holly; P Bertuccio; Y T Gao; M Hassan; H Yu; R C Kurtz; M Cotterchio; J Su; P Maisonneuve; E J Duell; P Boffetta; C La Vecchia
Journal:  Ann Oncol       Date:  2011-11-21       Impact factor: 32.976

8.  Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer.

Authors:  Nils D Arvold; David P Ryan; Andrzej Niemierko; Lawrence S Blaszkowsky; Eunice L Kwak; Jennifer Y Wo; Jill N Allen; Jeffrey W Clark; Raymond C Wadlow; Andrew X Zhu; Carlos Fernandez-Del Castillo; Theodore S Hong
Journal:  Cancer       Date:  2011-10-21       Impact factor: 6.860

9.  Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; James S Tomlinson; Andrew K Stewart; David P Winchester; Mark S Talamonti
Journal:  Cancer       Date:  2007-09-15       Impact factor: 6.860

Review 10.  Pancreatic cancer--EUS and early diagnosis.

Authors:  Lars Helmstaedter; Juergen Ferdinand Riemann
Journal:  Langenbecks Arch Surg       Date:  2008-02-05       Impact factor: 3.445
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.